Chief Strategy Officer
Chris Apolito has over twenty-five years of pharmaceutical and strategy consulting experience, with positions in discovery research, business development, and management consulting. His previous employers include GlaxoSmithKline, AVOS Life Sciences, and Campbell Alliance (Syneos).
While at GlaxoSmithKline, Chris’s scientific accomplishments led to multiple patent authorships and peer-reviewed publications. In business development roles, Chris was responsible for corporate strategy and reviewing in-licensing and out-licensing opportunities. For the last twenty years, Chris has led consulting engagements focused on corporate strategy, R&D portfolio strategy, and commercial assessments across the life science sector.
Chris earned an MBA from the University of North Carolina Kenan-Flagler School of Business as a member of Beta Gamma Sigma academic honor society. He has an MS from the University of Buffalo and a BS in Biochemistry from the University of Rochester.